Medicine and Dentistry
Patient
100%
Cardiac Troponin
83%
Myocardial Infarction
83%
Inpatient
80%
Acute Coronary Syndrome
52%
Troponin I
48%
Troponin
40%
Diagnosis
28%
Heart Muscle Injury
26%
Assay
23%
Plaque
22%
Coronary Artery Disease
21%
Assessment
20%
Coronary Computed Tomography Angiography
17%
Cardiovascular Risk
17%
Association
17%
Infarction
17%
Coronary Artery
15%
Death
15%
Cardiology
15%
Therapeutic Procedure
14%
Computed Tomography Angiography
13%
Acute Heart Infarction
13%
Cardiovascular System
12%
Endothelial Dysfunction
12%
Evaluation Study
11%
Cells
10%
Diagnostics
10%
Risk Stratification
10%
Woman
9%
Randomized Controlled Trial
9%
Heart Death
9%
Man
9%
Injury
9%
Combination Therapy
8%
Enalapril Maleate
8%
Age
8%
In Vitro
8%
Atherosclerotic Plaque
8%
Predictor
8%
Isotopes of Calcium
7%
Stable Angina Pectoris
7%
Plasma
7%
Systematic Review
7%
Prospective Cohort Study
6%
Endothelial Cell
6%
Endothelin Receptor
6%
Symptom
6%
Cardiac Catheterization
6%
Meta-Analysis
6%
Cardiovascular Disease
6%
Ejection Fraction
6%
Cytotechnology
6%
Specimen
6%
Hepatitis C
6%
End Stage Renal Disease
6%
Chronic Kidney Disease
6%
Pump
6%
Myocarditis
6%
Endothelial Progenitor Cell
6%
Infective Endocarditis
6%
Proprotein Convertase 9
6%
Frailty
6%
Angina Pectoris
6%
Coronary Artery Bypass Graft Surgery
6%
Antibody
6%
Chronic Obstructive Pulmonary Disease
6%
Lipid
6%
Fibrinolysis
6%
Aortic Stenosis
6%
Radial Artery
6%
Adipose Tissue
6%
Ticagrelor
6%
Arterial Stiffness
6%
Fatty Liver
6%
Arteriosclerotic Heart Disease
6%
Gene Linkage
6%
Patient Selection
6%
Vasculitis
6%
Adoption
6%
Pain
6%
Hazard Ratio
5%
Hospital
5%
Prevalence
5%
Analysis
5%
Computed Tomography
5%
Ischemic Heart Disease
5%
Endothelin
5%
Clinical Trial
5%
Nursing and Health Professions
Troponin
44%
Heart Infarction
38%
Diagnosis
25%
Acute Coronary Syndrome
20%
Assay
13%
Troponin I
10%
Patient
9%
Infarction
8%
Death
8%
Heart Muscle Injury
8%
Inpatient
7%
End Stage Renal Disease
6%
Bacterial Endocarditis
6%
Clinical Practice
6%
Classification
6%
Hospitalization
6%
Prospective Cohort Study
6%
Evaluation Study
6%
Patient Selection
6%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
26%
Heart Muscle Injury
12%
Mortality
9%
Cohort Study
9%
Troponin I
9%
Disability
8%
Chronic Obstructive Lung Disease
7%
Diseases
7%
Acute Heart Infarction
7%
Troponin
6%
Death
6%
Atrial Fibrillation
6%
Placebo
6%
Lipid
6%
Coronary Artery Atherosclerosis
6%
Endothelin Receptor
6%
Proprotein Convertase 9
6%
Hepatitis C
6%
Bacterial Endocarditis
6%
Aortic Stenosis
6%
Frailty
6%
Cardiovascular Risk
6%
Anticoagulation Therapy
6%
End Stage Renal Disease
6%
Chronic Kidney Failure
6%
Vascular Disease
6%
Myocarditis
6%